Analysts See $0.11 EPS for Amyris, Inc. (AMRS); Blackrock Muniyield Michigan Quality Fund (MIY) Has 0.86 Sentiment

February 11, 2018 - By Ellis Scott

It closed at $13.27 lastly. It is up 6.97% since February 11, 2017 and is downtrending. It has underperformed by 23.67% the S&P500.

Analysts expect Amyris, Inc. (NASDAQ:AMRS) to report $0.11 EPS on March, 1.They anticipate $1.61 EPS change or 107.33% from last quarter’s $-1.5 EPS. AMRS’s profit would be $4.73 million giving it 11.25 P/E if the $0.11 EPS is correct. After having $-1.14 EPS previously, Amyris, Inc.’s analysts see -109.65% EPS growth. The stock increased 2.06% or $0.1 during the last trading session, reaching $4.95. About 353,696 shares traded or 12.87% up from the average. Amyris, Inc. (NASDAQ:AMRS) has declined 47.38% since February 11, 2017 and is downtrending. It has underperformed by 64.08% the S&P500.

Among 4 analysts covering Amyris Inc (NASDAQ:AMRS), 3 have Buy rating, 0 Sell and 1 Hold. Therefore 75% are positive. Amyris Inc had 12 analyst reports since November 10, 2015 according to SRatingsIntel. The rating was maintained by Cowen & Co on Monday, September 18 with “Hold”. H.C. Wainwright maintained it with “Buy” rating and $15.0 target in Tuesday, September 26 report. Cowen & Co maintained Amyris, Inc. (NASDAQ:AMRS) rating on Wednesday, August 16. Cowen & Co has “Hold” rating and $3.5 target. On Thursday, January 25 the stock rating was initiated by FBR Capital with “Buy”. The firm has “Buy” rating given on Tuesday, November 10 by Rodman & Renshaw. H.C. Wainwright maintained the stock with “Buy” rating in Wednesday, June 7 report. The firm earned “Buy” rating on Wednesday, November 29 by H.C. Wainwright. Cowen & Co maintained Amyris, Inc. (NASDAQ:AMRS) on Friday, October 20 with “Hold” rating. H.C. Wainwright initiated it with “Buy” rating and $4 target in Tuesday, November 10 report. The firm has “Buy” rating by H.C. Wainwright given on Friday, August 11.

Amyris, Inc. provides various alternatives to a range of petroleum-sourced products worldwide. The company has market cap of $213.02 million. The firm uses its industrial bioscience technology to design microbes primarily yeast, as well as to convert plant-sourced sugars into renewable ingredients. It currently has negative earnings. It produces and sells Biofene that converts to squalane, which is used as an emollient in cosmetics and other personal care products; and natural oils and aroma chemicals for the flavors and fragrances market.

Karpus Management Inc. holds 0.3% of its portfolio in BlackRock MuniYield Michigan Quality Fund, Inc. for 413,879 shares. Mackay Shields Llc owns 451,928 shares or 0.23% of their US portfolio. Moreover, Walter & Keenan Financial Consulting Co Mi Adv has 0.14% invested in the company for 21,690 shares. The Minnesota-based Sit Investment Associates Inc has invested 0.13% in the stock. Liberty Capital Management Inc., a Michigan-based fund reported 6,272 shares.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>